Predicting Breast Cancer Outcomes Using AI Models and Federated Learning

In this Clinical OMICs webinar, sponsored by Owkin, a distinguished panel of breast cancer experts and machine learning researchers, including world-renowned expert Dr. Fabrice André, will explore how clinicians and data scientists can collaborate to accelerate research through the application of novel computational and federated learning techniques.
Cloned Faces with digital background

Whole-Genome Sequencing Comes of Age in Clinical Care

In this Clinical OMICs KEYNOTE webinar, sponsored by Illumina, we are delighted to host two true pioneers of clinical genome sequencing, bioinformatician Dr. Liz Worthey and geneticist Dr. Howard Jacob, who will reflect on a decade of progress in clinical genome analysis and discuss the future challenges confronting the field.
Clinical OMICs Keynote Webinar lead image

Newborn Genomic Screening: In Sickness and In Health

In this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis.
Oxford Nanopore eBook cover

Clinical Research in a Real-Time Sequencing Age

Oxford Nanopore’s DNA/RNA sequencing technology delivers ultra-long reads (up to 2 Mb), enabling rapid and comprehensive analysis of variants. With devices scalable from portable to benchtop, nanopore sequencing offers a cost-effective solution to the challenges faced by traditional sequencing platforms.

From Bench to Clinic—The Potential of New Sequencing Tools

Sponsored content brought to you by As genome sequencing technology advances, researchers are increasingly exploring emerging tools for a host of potential clinical applications. Andrew...
Conceptual Circuit Intelligence

Mainstreaming Precision Oncology

Sponsored content brought to you by   What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...
Researchers Operating Chemistry Analyzer Machine

Better Understanding of Post-Translation Modifications Driving Innovation

Takeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.

LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies

In this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.
isoplexis eBook cover

Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical Stages

IsoPlexis’ next generation systems provide actionable potency, safety, and patient difference metrics by detecting highly potent single cell functional subsets for the first time.
Scroll Up